Cutler Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,300
Closed -$10K 3021
2023
Q4
$10K Buy
4,300
+1,100
+34% +$642K ﹤0.01% 2396
2023
Q3
$55K Sell
3,200
-800
-20% -$412K 0.01% 1458
2023
Q2
$70K Buy
+4,000
New +$1.68M 0.01% 1117
2023
Q1
Sell
-23,500
Closed -$3K 4318
2022
Q4
$3K Sell
23,500
-17,800
-43% -$6.31M ﹤0.01% 3498
2022
Q3
$126K Sell
41,300
-15,000
-27% -$4.75M 0.01% 1226
2022
Q2
$320K Sell
56,300
-17,800
-24% -$5.34M 0.02% 731
2022
Q1
$328K Buy
74,100
+47,600
+180% +$12.3M 0.02% 886
2021
Q4
$131K Buy
26,500
+21,500
+430% +$5.45M 0.01% 1644
2021
Q3
$9K Buy
+5,000
New +$1.23M ﹤0.01% 4018
2019
Q3
Sell
-8,500
Closed -$11K 4417
2019
Q2
$11K Sell
8,500
-3,000
-26% -$353K ﹤0.01% 2616
2019
Q1
$3K Buy
+11,500
New +$1.4M ﹤0.01% 3207
2017
Q4
Sell
-1,100
Closed -$1K 5447
2017
Q3
$1K Sell
1,100
-7,400
-87% -$607K ﹤0.01% 5458
2017
Q2
$7K Sell
8,500
-8,000
-48% -$653K ﹤0.01% 4529
2017
Q1
$22K Sell
16,500
-195,200
-92% -$15.6M ﹤0.01% 3234
2016
Q4
$1.19M Buy
211,700
+150,400
+245% +$11.2M 0.04% 348
2016
Q3
$95K Sell
61,300
-14,500
-19% -$1.16M ﹤0.01% 1860
2016
Q2
$31K Buy
75,800
+66,500
+715% +$5.01M ﹤0.01% 2868
2016
Q1
$32K Sell
9,300
-1,400
-13% -$106K ﹤0.01% 2779
2015
Q4
$2K Buy
+10,700
New +$888K ﹤0.01% 5573

Other funds holding LLY

Cutler Group's LLY Position: Q1 2024 in Review

Cutler Group sold out of Eli Lilly (LLY) in Q1 2024, closing a stake of 809 shares — an estimated $576K sold.

Cutler Group first reported a position in LLY in Q4 2015 and held it in 18 quarters. The position peaked at $9.94M in Q4 2016. 3,460 funds tracked by Wall St. Rank hold LLY as of Q1 2024.

  • Cutler Group reported no remaining Eli Lilly position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 809 Eli Lilly shares in Q1 2024, an estimated $576K.
  • Cutler Group first reported a position in Eli Lilly in Q4 2015 and held it in 18 quarters.
  • Cutler Group's Eli Lilly position peaked at $9.94M in Q4 2016.
  • 3,460 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.